Novus Scientific has reported the US sales launch of TIGR Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC. TIGR Matrix Surgical Mesh had been FDA cleared in February 2010, for use in reinforcement of soft tissues where weakness exists.
Novus Scientific TIGR Matrix Surgical Mesh is knitted from two different resorbable fibers that degrade at different rates following implantation.
TIGR Matrix Surgical Mesh’s patented dual-fibre design is expected to provide an initial high strength and stability configuration, with gradually increasing compliance over time as the device is resorbed. The macroporous structure is designed to allow tissue integration for reliable tissue repair.
David Earle, assistant professor of surgery at Tufts University School of Medicine, Springfield, said: “The TIGR prosthetic adds a tool to the surgeon’s armamentarium that is currently missing a long acting, synthetic, absorbable product that may not only be beneficial in hernia patients, but also for prophylaxis, potentially preventing the hernia from ever forming in the first place.”
Jim Archetto, president of Novus Scientific, said: “TIGR Matrix Surgical Mesh begins a new era in patient treatment. While there is a wide range of potential applications for such a unique product, at today’s Abdominal Wall Reconstruction meeting there has been particular interest in use of TIGR Matrix for onlay or sublay reinforcement in conjunction with the component separation technique.”
Karl Leblanc, past president of the American Hernia Society, said: “TIGR Matrix Surgical Mesh fills a gap between traditional permanent mesh and biologic prosthetics. This long-term resorbable synthetic mesh defines a new product category that has never existed before, and I see many potential applications for it.”